Hyderabad Paediatrician’s Eight-Year Battle Leads to FSSAI Prohibiting Usage of ‘ORS’ on Food Products

In a landmark decision reinforcing the sanctity of medical terminology and consumer protection, the Food Safety and Standards Authority of India (FSSAI) has officially prohibited the use of the term ‘ORS’ (Oral Rehydration Salts) on any food or non-pharmaceutical product. This decisive move comes after an eight-year relentless campaign by a Hyderabad-based paediatrician, whose sustained efforts exposed misleading marketing practices that could endanger public health.

The Long Fight for Clarity and Consumer Safety

Dr. [Name withheld], a practising paediatrician from Hyderabad, first raised the issue in 2017 when several beverage and wellness brands began using the term ‘ORS’ on their product labels. These drinks were marketed as “rehydration solutions” or “energy restorers,” often placed alongside genuine medical-grade oral rehydration salts in pharmacies and online marketplaces.

Concerned that such labeling could confuse consumers — especially parents seeking rehydration therapy for children suffering from diarrhoea or dehydration — Dr. [Name] began petitioning health authorities and the FSSAI. He argued that using the term ‘ORS’ for commercial beverages diluted the medical value of the formula, potentially misleading the public into choosing unregulated drinks over scientifically formulated rehydration therapies approved by the World Health Organization (WHO).

Understanding the Misuse of ‘ORS’

The genuine ORS formula is a precise medical mixture of glucose and salts, developed to prevent dehydration and save lives — especially in children suffering from diarrhoeal diseases. It is a low-cost, evidence-based treatment recommended globally by the WHO and UNICEF.

However, many commercial products misused the same terminology to imply medicinal benefits. These drinks often contained added sugars, flavoring agents, and preservatives, lacking the correct ratio of electrolytes necessary for effective rehydration. As Dr. [Name] emphasized, “What these companies were selling was not ORS — it was flavored water with salt and sugar. Using the name ‘ORS’ for such products was both unethical and dangerous.”

FSSAI’s Intervention and Final Ruling

After years of sustained correspondence, advocacy, and formal complaints, the FSSAI finally reviewed the matter in detail. Following expert consultation, the authority concluded that the use of ‘ORS’ on non-medical food products constitutes misleading labeling and violates India’s Food Safety and Standards (Advertising and Claims) Regulations.

In its directive, the FSSAI stated that ‘ORS’ is a pharmaceutical term reserved for products conforming to the standards prescribed under the Indian Pharmacopoeia and cannot be used for any food, beverage, or nutraceutical product. The authority has instructed all food manufacturers to cease using the term ‘ORS’ in branding, marketing, or labeling, effective immediately.

A Victory for Ethics and Public Health

Dr. [Name]’s unwavering determination highlights the critical role of medical professionals in safeguarding ethical standards beyond the clinic. His advocacy not only led to regulatory reform but also raised public awareness about the dangers of medical mimicry in consumer marketing.

“This is not just a victory for doctors — it’s a victory for every parent and every child,” Dr. [Name] said following the announcement. “Words like ORS carry life-saving importance. They should not be misused for profit.”

Broader Implications for the Food Industry

The ruling is expected to have a far-reaching impact on the Indian food and beverage industry. Companies selling electrolyte drinks, energy beverages, or wellness tonics will now need to rebrand their products and ensure that no medical terminology is used without scientific validation and regulatory approval.

Consumer-rights advocates have welcomed the decision, noting that the misuse of medical terms in food marketing has long been a grey area. The FSSAI’s order sets a clear precedent that health-related claims must be backed by evidence and must not blur the line between medicine and food.

Conclusion

The Hyderabad paediatrician’s eight-year struggle stands as a testament to perseverance and civic responsibility. His campaign has not only corrected a regulatory loophole but has reaffirmed that public health terminology is not for sale.

In a time when marketing often overshadows science, this case is a reminder that vigilance, persistence, and ethical advocacy can protect millions — ensuring that critical medical interventions like ORS remain what they were meant to be: a trusted, life-saving remedy, not a marketing gimmick.